Sept. 5 (UPI) -- The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that could be used in GLP-1 drugs that include Wegovy, Ozembic and Mounjaro. The drugs are use for treating Type 2 diabetes and, in certain cases, for weight loss. The FDA announced Friday it published a "green list" of import alert to stop the unverified foreign sources from coming into the U.S. market. Other GLP-1 drugs, some of which are older medications,